MPM ASSET MANAGEMENT LLC - Q1 2023 holdings

$240 Million is the total value of MPM ASSET MANAGEMENT LLC's 9 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .

 Value Shares↓ Weighting
 Entrada Therapeutics, Inc.$64,173,868
+7.2%
4,425,7840.0%26.74%
+6.8%
DYN  Dyne Therapeutics, Inc.$57,039,011
-0.6%
4,951,3030.0%23.77%
-1.0%
AMYT  Amryt Pharma plc$38,911,731
+99.7%
2,668,8430.0%16.21%
+98.9%
ITOS  iTeos Therapeutics, Inc.$37,274,864
-30.3%
2,738,7850.0%15.53%
-30.6%
RPTX  Repare Therapeutics, Inc.$22,067,538
-33.1%
2,242,6360.0%9.20%
-33.4%
HOWL  Werewolf Therapeutics, Inc.$11,138,847
+26.8%
4,284,1720.0%4.64%
+26.3%
TCRR  TCR2 Therapeutics, Inc.$6,076,298
+50.2%
4,050,8650.0%2.53%
+49.6%
HARP  Harpoon Therapeutics, Inc.$2,329,753
+2.5%
3,131,3880.0%0.97%
+2.1%
ONCR  Oncorus, Inc.$980,216
+36.0%
2,849,4640.0%0.41%
+35.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Export MPM ASSET MANAGEMENT LLC's holdings